LYG-202
LYG-202 is a novel piperazine-substituted flavonoid exhibiting antitumor activity. It induces apoptosis and elevates reactive oxygen species (ROS) in breast cancer cell lines such as MCF-7, MDA-MB-231, and MDA-MB-435, demonstrating potential for oncology research in both cellular and animal models.
Product Specifications
CAS Number
1175077-25-4
Product Name Alternative
ROS, Apoptosis, LYG 202, LYG202, LYG-202
Field of Research
Cell Biology, Immunology & Inflammation
Purity
97.27% (May vary between batches)
Solubility
Ethanol:2.5 mg/mL (5.7 mM) ; DMF:14 mg/mL (31.93 mM) ; DMF:PBS (pH7.2) (1:40) :0.12 mg/mL (0.27 mM) ; DMSO:4.39 mg/mL (10.01 mM)
Smiles
COc1c (OCCCCN2CCN (C) CC2) cc (O) c2c1oc (cc2=O) -c1ccccc1
Molecular Formula
C25H30N2O5
Molecular Weight
438.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15129853 1 Vial
Lentiviral human SLC3A1 shRNA (UAS) - Lentiviral human SLC3A1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 